Screening South Asians for type 2 diabetes and prediabetes: (1) comparing oral glucose tolerance and haemoglobin A1c test results and (2) comparing the two sets of metabolic profiles of individuals diagnosed with these two tests

BMC Endocrine Disorders

Irene GM van Valkengoed³  Karien Stronks³  Barend JC Middelkoop¹  Vera Nierkens³  Frits Holleman²  Wim B Busschers³  Wanda M Admiraal²  Everlina MA Vlaar³ 

[1] Public Health Service, The Hague, The Netherlands;Department of Internal Medicine, Academic Medical Centre, Amsterdam, Netherlands;Department of Public Health, Academic Medical Centre, University of Amsterdam, Meibergdreef 15, Amsterdam 1105 AZ, The Netherlands

关键词: OGTT;    HbA1c;    Screening;    South Asian Populations;    Prediabetes;    Type 2 Diabetes;   

Others  :  1085961
DOI  :  10.1186/1472-6823-13-8

 received in 2012-10-02, accepted in 2013-02-19,  发布年份 2013

【 摘 要 】

Background

The glycated haemoglobin A1c (HbA1c) level may be used for screening for type 2 diabetes and prediabetes instead of a more burdensome oral glucose tolerance test (OGTT). However, among the high-risk South Asian population, little is known about the overlap of the methods or about the metabolic profiles of those disconcordantly diagnosed.

Methods

We included 944 South Asians (18–60 years old), whom we screened with the HbA1c level and the OGTT in The Hague, the Netherlands. We calculated the area under the receiver-operator characteristic curve (AUROC) with a 95% confidence interval of HbA1c using the American Diabetes Association classifications, and determined the sensitivity and specificity with 95% confidence intervals at different thresholds. Moreover, we studied differences in metabolic characteristics between those identified by HbA1c and by the OGTT alone.

Results

The overlap between HbA1c and OGTT classifications was partial, both for diabetes and prediabetes. The AUROC of HbA1c for OGTT defined diabetes was 0.86 (0.79–0.93). The sensitivity was 0.46 (0.29–0.63); the specificity 0.98 (0.98–0.99). For prediabetes, the AUROC was 0.73 (0.69–0.77). Each of the 31 individuals with diabetes and 353 with prediabetes identified with the HbA1c level had a high body mass index, large waist circumference, high blood pressure, and low insulin sensitivity, all of which were similar to the values shown by those among the 19 with diabetes or 62 with prediabetes who only met the OGTT criteria, but not the HbA1c criteria.

Conclusions

The HbA1c level identified a partially different group than the OGTT did. However, both those identified with the HbA1c level and those identified with the OGTT alone were at increased metabolic risk.

Trial registration

Dutch Trial Register:NTR1499

【 授权许可】

   
2013 Vlaar et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Wild SH, Smith FB, Lee AJ, Fowkes FG: Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort. Diabet Med 2005, 22:490-496.
• [2]Gholap N, Davies M, Patel K, Sattar N, Khunti K: Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes 2011, 5:45-56.
• [3]Bindraban NR, Valkengoed IG V, Mairuhu G, Holleman F, Hoekstra JB, Michels BP, Koopmans RP, Stronks K: Prevalence of diabetes mellitus and the performance of a risk score among Hindustani Surinamese, African Surinamese and ethnic Dutch: a cross-sectional population-based study. BMC Public Health 2008, 8:271. BioMed Central Full Text
• [4]Webb DR, Gray LJ, Khunti K, Srinivasan B, Taub N, Campbell S, Barnett J, Farooqi A, Echouffo-Tcheugui JB, Griffin SJ, Wareham NJ, Davies MJ: Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 2011, 54:2237-2246.
• [5]American Diabetes Association: Standards of medical care in diabetes--2010. Diabetes Care 2010, 33(Suppl 1):S11-S61.
• [6]Christensen DL, Witte DR, Kaduka L, Jorgensen ME, Borch-Johnsen K, Mohan V, Shaw JE, Tabak AG, Vistisen D: Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010, 33:580-582.
• [7]Lorenzo C, Haffner SM: Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2010, 33:335-337.
• [8]Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS: Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010, 33:2184-2189.
• [9]Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P: Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 2010, 33:2190-2195.
• [10]Mohan V, Vijayachandrika V, Gokulakrishnan K, Anjana RM, Ganesan A, Weber MB, Narayan KM: A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care 2010, 33:515-519.
• [11]Kumar PR, Bhansali A, Ravikiran M, Bhansali S, Dutta P, Thakur JS, Sachdeva N, Bhadada SK, Walia R: Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab 2010, 95:2832-2835.
• [12]Nazir A, Papita R, Anbalagan VP, Anjana RM, Deepa M, Mohan V: Prevalence of diabetes in Asian Indians based on glycated hemoglobin and fasting and 2-H post-load (75-g) plasma glucose (CURES-120). Diabetes Technol Ther 2012, 14:665-668.
• [13]Mostafa SA, Davies MJ, Webb DR, Srinivasan BT, Gray LJ, Khunti K: Independent effect of ethnicity on glycemia in South Asians and white Europeans. Diabetes Care 2012, 35:1746-1748.
• [14]Boronat M, Saavedra P, Lopez-Rios L, Riano M, Wagner AM, Novoa FJ: Differences in cardiovascular risk profile of diabetic subjects discordantly classified by diagnostic criteria based on glycated hemoglobin and oral glucose tolerance test. Diabetes Care 2010, 33:2671-2673.
• [15]Borg R, Vistisen D, Witte DR, Borch-Johnsen K: Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study. Diabet Med 2010, 27:906-910.
• [16]Choenni C, Harmsen C: Place of birth and ethnic composition of the Surinamese in the Netherlands [in Dutch]. Bevolkingtrends 2007, 1:74-78.
• [17]Vlaar EM, Valkengoed IGV, Nierkens V, Nicolaou M, Middelkoop BJ, Stronks K: Feasibility and effectiveness of a targeted diabetes prevention program for 18 to 60-year-old South Asian migrants: design and methods of the DH!AAN study. BMC Public Health 2012, 12:371. BioMed Central Full Text
• [18]The Oxford Centre for Diabetes, Endocrinology & Metabolism, Diabetes Trial Unit: HOMA calculator. 2004. http://www.dtu.ox.ac.uk/homacalculator/index.php webcite
• [19]Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):S62-S69.
• [20]Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD: VergouweY, Habbema JD: Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001, 54:774-781.
• [21]Carson AP, Reynolds K, Fonseca VA, Muntner P: Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010, 33:95-97.
• [22]Lu ZX, Walker KZ, O’Dea K, Sikaris KA, Shaw JE: A1C for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care 2010, 33:817-819.
• [23]Mostafa S, Khunti K, Kilpatrick E, Webb D, Srinivasan B, Gray L, Davies M: Diagnostic performance of using one- or two-HbA1c cut-point strategies to detect undiagnosed type 2 diabetes and impaired glucose regulation within a multi-ethnic population. Diab Vasc Dis Res 2013, 10:84-92.
• [24]World Health Organization: Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus Screening for Type 2 diabetes. 2011. http://www.who.int/diabetes/publications/report-hba1c_2011.pdf webcite
• [25]Dong XL, Liu Y, Sun Y, Sun C, Fu FM, Wang SL, Chen L: Comparison of HbA1c and OGTT criteria to diagnose diabetes among Chinese. Exp Clin Endocrinol Diabetes 2011, 119:366-369.
• [26]Van Dis I, Kromhout D, Geleijnse JM, Boer JM, Verschuren WM: Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20–65 years. Eur J Cardiovasc Prev Rehabil 2009, 16:729-734.
• [27]Mangalmurti S, Paley A, Gany F, Fisher E, Hochman J: South Asians and risk of cardiovascular disease: current insights and trends. Ethn Dis 2010, 20:474-478.
• [28]Shields M, Tremblay M, Gorber S, Janssen I: Abdominal obesity and cardiovascular disease risk factors within body mass index categories. Health Rep 2012, 23:7-12.
• [29]Harding S, Maynard MJ, Cruickshank K, Teyhan A: Overweight, obesity and high blood pressure in an ethnically diverse sample of adolescents in Britain: the Medical Research Council DASH study. Int J Obes (Lond) 2008, 32:82-90.
• [30]Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A: Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol 2007, 36:220-225.
• [31]Douglas A, Bhopal RS, Bhopal R, Forbes J, Gill J, Lawton J, McKnight J, Murray G, Sattar N, Sharma A, Tuomilehto J, Wallia S, Wild SSA: Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians). Trials 2011, 12:220. BioMed Central Full Text
• [32]Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811.
• [33]Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM: A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010, 33:2104-2109.
• [34]Rutten GEHM, De Grauw WJC, Nijpels G, Goudswaard AN, Uitewaal PJM, Van der Does FEE, et al.: NHG-Standaard Diabetes mellitus type 2. Tweede herziening. Huisartsen Wet, Dutch College of General Practitioners - Standard type 2 diabetes mellitus. Second revision. GP Act 2006, 49(3):137-152.